Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Albendazole | hsa00010 | Glycolysis / Gluconeogenesis | 1.18E-02 | 2 | P60174, P06744 | TPI1, GPI | More | | Albendazole | hsa00051 | Fructose and mannose metabolism | 3.92E-03 | 3 | P15121, P19367, P08237 | AKR1B1, HK1, PFKM | More | | Albendazole | hsa00052 | Galactose metabolism | 3.92E-03 | 3 | P08237, P15121, P19367 | PFKM, AKR1B1, HK1 | More | | Albendazole | hsa00053 | Ascorbate and aldarate metabolism | 1.80E-02 | 2 | P51648, Q9UEF7 | ALDH3A2, KL | More | | Albendazole | hsa00310 | Lysine degradation | 4.27E-02 | 2 | Q96KQ7, P51648 | EHMT2, ALDH3A2 | More | | Albendazole | hsa00512 | Mucin type O-glycan biosynthesis | 3.78E-02 | 2 | O95395, Q8N4A0 | GCNT3, GALNT4 | More | | Albendazole | hsa00561 | Glycerolipid metabolism | 4.36E-03 | 3 | O14494, P51648, P23743 | PLPP1, ALDH3A2, DGKA | More | | Albendazole | hsa00564 | Glycerophospholipid metabolism | 3.56E-02 | 3 | P48651, Q9Y6K0, P35790 | PTDSS1, CEPT1, CHKA | More | | Albendazole | hsa00590 | Arachidonic acid metabolism | 3.85E-02 | 2 | P11712, P09960 | CYP2C9, LTA4H | More | | Albendazole | hsa00591 | Linoleic acid metabolism | 4.07E-02 | 1 | P11712 | CYP2C9 | More | | Albendazole | hsa00630 | Glyoxylate and dicarboxylate metabolism | 2.42E-02 | 2 | P40925, P15104 | MDH1, GLUL | More | | Albendazole | hsa00970 | Aminoacyl-tRNA biosynthesis | 3.78E-02 | 2 | O95363, Q15046 | FARS2, KARS | More | | Albendazole | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 9.14E-03 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | | Albendazole | hsa00982 | Drug metabolism - cytochrome P450 | 9.14E-03 | 2 | P11712, P78417 | CYP2C9, GSTO1 | More | | Albendazole | hsa01100 | Metabolic pathways | 1.28E-02 | 16 | Q9Y234, P35790, Q16772, P30041, P19367, P48426, P22557, P20839, Q9Y6K0, P15121, P08237, O95861, Q86VZ5, P48651, Q969G6, P14927 | LIPT1, CHKA, GSTA3, PRDX6, HK1, PIP4K2A, ALAS2, IMPDH1, CEPT1, AKR1B1, PFKM, BPNT1, SGMS1, PTDSS1, RFK, UQCRB | More | | Albendazole | hsa01200 | Carbon metabolism | 1.99E-02 | 2 | P06744, P60174 | GPI, TPI1 | More | | Albendazole | hsa01240 | Biosynthesis of cofactors | 4.63E-02 | 3 | Q969G6, P22557, Q9Y234 | RFK, ALAS2, LIPT1 | More | | Albendazole | hsa01521 | EGFR tyrosine kinase inhibitor resistance | 2.90E-02 | 3 | P17252, P10415, Q9NRA1 | PRKCA, BCL2, PDGFC | More | | Albendazole | hsa01524 | Platinum drug resistance | 4.02E-02 | 4 | Q13315, P10415, Q13489, P43246 | ATM, BCL2, BIRC3, MSH2 | More | | Albendazole | hsa03013 | RNA transport | 4.49E-02 | 5 | P62826, Q9UBU9, P63279, P68104, Q14232 | RAN, NXF1, UBE2I, EEF1A1, EIF2B1 | More | | Albendazole | hsa03020 | RNA polymerase | 6.21E-04 | 4 | P30876, P24928, P62487, Q9Y535 | POLR2B, POLR2A, POLR2G, POLR3H | More | | Albendazole | hsa03040 | Spliceosome | 1.17E-08 | 15 | Q14562, O43143, O60508, P08579, P26368, P52298, Q13595, Q07955, Q01130, P84103, Q13243, P11142, Q9Y2W2, O43447, O75643 | DHX8, DHX15, CDC40, SNRPB2, U2AF2, NCBP2, TRA2A, SFRS1, SFRS2, SFRS3, SFRS5, HSPA8, WBP11, PPIH, ASCC3L1 | More | | Albendazole | hsa04014 | Ras signaling pathway | 2.36E-02 | 8 | P42338, P20827, P49767, Q13009, Q7LDG7, P63218, P50151, P19174 | PIK3CB, EFNA1, VEGFC, TIAM1, RASGRP2, GNG5, GNG10, PLCG1 | More | | Albendazole | hsa04015 | Rap1 signaling pathway | 1.79E-02 | 8 | P20827, P49767, Q96FS4, P11215, Q13009, Q7LDG7, P42338, P19174 | EFNA1, VEGFC, SIPA1, ITGAM, TIAM1, RASGRP2, PIK3CB, PLCG1 | More | | Albendazole | hsa04020 | Calcium signaling pathway | 2.70E-03 | 8 | Q08828, Q16566, P17252, P25116, P0DP23, P05141, P51828, Q9NRA1 | ADCY1, CAMK4, PRKCA, F2R, CALM1, SLC25A5, ADCY7, PDGFC | More | | Albendazole | hsa04022 | cGMP-PKG signaling pathway | 4.38E-03 | 6 | P18848, P31751, Q08828, P51828, P05141, P0DP23 | ATF4, AKT2, ADCY1, ADCY7, SLC25A5, CALM1 | More | | Albendazole | hsa04024 | cAMP signaling pathway | 3.94E-02 | 4 | Q08828, P51828, P31751, P0DP23 | ADCY1, ADCY7, AKT2, CALM1 | More | | Albendazole | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 4.54E-02 | 2 | Q8NHW4, Q13651 | CCL4L2, IL10RA | More | | Albendazole | hsa04062 | Chemokine signaling pathway | 9.23E-03 | 10 | P09769, P07948, P42338, P19174, P63218, P50151, P43250, Q7LDG7, Q13009, Q8WYR1 | FGR, LYN, PIK3CB, PLCG1, GNG5, GNG10, GRK6, RASGRP2, TIAM1, PIK3R5 | More | | Albendazole | hsa04064 | NF-kappa B signaling pathway | 6.71E-05 | 12 | P10415, Q13489, P25963, P51617, Q13546, P01584, Q9UDY8, Q13315, P63279, O75293, Q8NHW4, Q9NQC7 | BCL2, BIRC3, NFKBIA, IRAK1, RIPK1, IL1B, MALT1, ATM, UBE2I, GADD45B, CCL4L2, CYLD | More | | Albendazole | hsa04070 | Phosphatidylinositol signaling system | 9.86E-03 | 4 | P0DP23, O14986, Q16760, P48426 | CALM1, PIP5K1B, DGKD, PIP4K2A | More | | Albendazole | hsa04071 | Sphingolipid signaling pathway | 2.03E-02 | 4 | P17252, P21453, P10415, P01042 | PRKCA, S1PR1, BCL2, KNG1 | More | | Albendazole | hsa04072 | Phospholipase D signaling pathway | 7.60E-05 | 11 | P31751, P25116, P17252, O14986, Q15438, Q08828, P51828, O14494, P23743, Q16760, Q9NRA1 | AKT2, F2R, PRKCA, PIP5K1B, PSCD1, ADCY1, ADCY7, PLPP1, DGKA, DGKD, PDGFC | More | | Albendazole | hsa04114 | Oocyte meiosis | 1.35E-02 | 5 | P0DP23, Q08828, P51828, Q13362, Q14738 | CALM1, ADCY1, ADCY7, PPP2R5C, PPP2R5D | More | | Albendazole | hsa04140 | Autophagy - animal | 1.71E-02 | 5 | P31751, Q7L523, O75460, Q96GC9, Q8TEV9 | AKT2, RRAGA, ERN1, TMEM49, SMCR8 | More | | Albendazole | hsa04141 | Protein processing in endoplasmic reticulum | 2.77E-02 | 5 | P27824, P30101, P60604, P11142, P08238 | CANX, PDIA3, UBE2G2, HSPA8, HSP90AB1 | More | | Albendazole | hsa04145 | Phagosome | 2.46E-03 | 6 | Q15080, P14598, Q13509, P68371, Q13488, P27824 | NCF4, NCF1, TUBB3, TUBB2C, TCIRG1, CANX | More | | Albendazole | hsa04151 | PI3K-Akt signaling pathway | 3.70E-02 | 12 | P42338, P43657, P20827, P49767, P08238, Q8WYR1, P63218, P50151, O15335, Q13751, P14784, P30281 | PIK3CB, P2RY5, EFNA1, VEGFC, HSP90AB1, PIK3R5, GNG5, GNG10, CHAD, LAMB3, IL2RB, CCND3 | More | | Albendazole | hsa04211 | Longevity regulating pathway | 1.88E-02 | 4 | P31751, Q08828, P51828, P18848 | AKT2, ADCY1, ADCY7, ATF4 | More | | Albendazole | hsa04213 | Longevity regulating pathway - multiple species | 4.54E-02 | 3 | P31751, Q08828, P51828 | AKT2, ADCY1, ADCY7 | More | | Albendazole | hsa04217 | Necroptosis | 3.69E-05 | 8 | P01568, Q13489, Q13546, P42224, P08238, Q6FI13, P10415, O43633 | IFNA21, BIRC3, RIPK1, STAT1, HSP90AB1, H2AC18; H2AC19, BCL2, CHMP2A | More | | Albendazole | hsa04261 | Adrenergic signaling in cardiomyocytes | 4.98E-04 | 7 | Q08828, P51828, P31751, P18848, Q13362, Q14738, P0DP23 | ADCY1, ADCY7, AKT2, ATF4, PPP2R5C, PPP2R5D, CALM1 | More | | Albendazole | hsa04360 | Axon guidance | 4.04E-02 | 6 | P16333, P20827, O95631, P42338, P07332, P19174 | NCK1, EFNA1, NTN1, PIK3CB, FES, PLCG1 | More | | Albendazole | hsa04371 | Apelin signaling pathway | 4.77E-06 | 14 | P62873, P63218, P50151, Q8WYR1, P31751, Q08828, P51828, Q13370, Q14814, Q14344, Q13485, P84022, Q16566, P0DP23 | GNB1, GNG5, GNG10, PIK3R5, AKT2, ADCY1, ADCY7, PDE3B, MEF2D, GNA13, SMAD4, SMAD3, CAMK4, CALM1 | More | | Albendazole | hsa04380 | Osteoclast differentiation | 1.88E-02 | 4 | Q9NQC7, P23458, P31751, P01584 | CYLD, JAK1, AKT2, IL1B | More | | Albendazole | hsa04520 | Adherens junction | 8.77E-03 | 4 | Q13485, P84022, O95863, Q15223 | SMAD4, SMAD3, SNAI1, PVRL1 | More | | Albendazole | hsa04530 | Tight junction | 3.29E-02 | 3 | P16989, P56750, Q14247 | CSDA, CLDN17, CTTN | More | | Albendazole | hsa04540 | Gap junction | 5.44E-03 | 4 | P17252, Q13509, P68371, Q9NRA1 | PRKCA, TUBB3, TUBB2C, PDGFC | More | | Albendazole | hsa04610 | Complement and coagulation cascades | 3.19E-02 | 1 | P0C0L4 | C4A | More | | Albendazole | hsa04613 | Neutrophil extracellular trap formation | 1.73E-02 | 4 | Q93077, P62807, O60814, P68431 | HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | | Albendazole | hsa04620 | Toll-like receptor signaling pathway | 5.45E-05 | 8 | P51617, Q13546, P01568, P01584, P31751, P42224, P25963, Q8NHW4 | IRAK1, RIPK1, IFNA21, IL1B, AKT2, STAT1, NFKBIA, CCL4L2 | More | | Albendazole | hsa04621 | NOD-like receptor signaling pathway | 4.54E-02 | 7 | P08238, P42224, P01568, P25963, Q13489, P10415, Q13546 | HSP90AB1, STAT1, IFNA21, NFKBIA, BIRC3, BCL2, RIPK1 | More | | Albendazole | hsa04623 | Cytosolic DNA-sensing pathway | 2.19E-08 | 6 | P01584, P01568, Q13546, P25963, Q9Y535, Q8NHW4 | IL1B, IFNA21, RIPK1, NFKBIA, POLR3H, CCL4L2 | More | | Albendazole | hsa04625 | C-type lectin receptor signaling pathway | 9.86E-03 | 4 | P01584, Q9NQC7, P31751, P0DP23 | IL1B, CYLD, AKT2, CALM1 | More | | Albendazole | hsa04630 | JAK-STAT signaling pathway | 4.54E-02 | 3 | P31751, P23458, Q13651 | AKT2, JAK1, IL10RA | More | | Albendazole | hsa04659 | Th17 cell differentiation | 1.01E-03 | 7 | P19174, P14784, P14778, P84022, Q13485, P08238, P07766 | PLCG1, IL2RB, IL1R1, SMAD3, SMAD4, HSP90AB1, CD3E | More | | Albendazole | hsa04662 | B cell receptor signaling pathway | 1.74E-02 | 5 | P42338, P60033, P07948, P21854, Q8N149 | PIK3CB, CD81, LYN, CD72, LILRA2 | More | | Albendazole | hsa04664 | Fc epsilon RI signaling pathway | 1.69E-03 | 4 | P42338, P07948, P19174, P09917 | PIK3CB, LYN, PLCG1, ALOX5 | More | | Albendazole | hsa04666 | Fc gamma R-mediated phagocytosis | 2.81E-02 | 4 | P23528, O14494, P14598, P17252 | CFL1, PLPP1, NCF1, PRKCA | More | | Albendazole | hsa04710 | Circadian rhythm | 1.79E-02 | 1 | O15516 | CLOCK | More | | Albendazole | hsa04713 | Circadian entrainment | 4.54E-02 | 3 | P0DP23, Q08828, P51828 | CALM1, ADCY1, ADCY7 | More | | Albendazole | hsa04720 | Long-term potentiation | 2.23E-03 | 5 | P17252, Q16566, P0DP23, P18848, Q08828 | PRKCA, CAMK4, CALM1, ATF4, ADCY1 | More | | Albendazole | hsa04724 | Glutamatergic synapse | 4.43E-02 | 3 | P63218, P50151, P15104 | GNG5, GNG10, GLUL | More | | Albendazole | hsa04725 | Cholinergic synapse | 2.86E-04 | 8 | Q08828, P51828, P17252, P62873, P18848, Q16566, P31751, P10415 | ADCY1, ADCY7, PRKCA, GNB1, ATF4, CAMK4, AKT2, BCL2 | More | | Albendazole | hsa04727 | GABAergic synapse | 4.43E-02 | 3 | P63218, P50151, P15104 | GNG5, GNG10, GLUL | More | | Albendazole | hsa04728 | Dopaminergic synapse | 7.83E-03 | 5 | P31751, P18848, Q13362, Q14738, P0DP23 | AKT2, ATF4, PPP2R5C, PPP2R5D, CALM1 | More | | Albendazole | hsa04744 | Phototransduction | 8.61E-05 | 2 | P62873, P0DP23 | GNB1, CALM1 | More | | Albendazole | hsa04750 | Inflammatory mediator regulation of TRP channels | 9.86E-03 | 4 | P01584, Q08828, P51828, P0DP23 | IL1B, ADCY1, ADCY7, CALM1 | More | | Albendazole | hsa04911 | Insulin secretion | 2.40E-02 | 3 | Q08828, P51828, P18848 | ADCY1, ADCY7, ATF4 | More | | Albendazole | hsa04912 | GnRH signaling pathway | 1.39E-02 | 4 | Q08828, P51828, P18848, P0DP23 | ADCY1, ADCY7, ATF4, CALM1 | More | | Albendazole | hsa04915 | Estrogen signaling pathway | 2.13E-02 | 5 | P18848, Q08828, P51828, P31751, P0DP23 | ATF4, ADCY1, ADCY7, AKT2, CALM1 | More | | Albendazole | hsa04916 | Melanogenesis | 1.60E-03 | 5 | P0DP23, Q9UJU2, Q08828, P51828, P17252 | CALM1, LEF1, ADCY1, ADCY7, PRKCA | More | | Albendazole | hsa04923 | Regulation of lipolysis in adipocytes | 5.15E-03 | 3 | Q08828, P51828, P31751 | ADCY1, ADCY7, AKT2 | More | | Albendazole | hsa04925 | Aldosterone synthesis and secretion | 9.43E-04 | 6 | P18848, Q08828, P51828, P0DP23, P17252, Q16566 | ATF4, ADCY1, ADCY7, CALM1, PRKCA, CAMK4 | More | | Albendazole | hsa04926 | Relaxin signaling pathway | 2.46E-02 | 4 | P31751, P18848, Q08828, P51828 | AKT2, ATF4, ADCY1, ADCY7 | More | | Albendazole | hsa04927 | Cortisol synthesis and secretion | 1.59E-02 | 3 | P18848, Q08828, P51828 | ATF4, ADCY1, ADCY7 | More | | Albendazole | hsa04932 | Non-alcoholic fatty liver disease | 1.04E-02 | 5 | P31751, P18848, O75460, P01584, O95298 | AKT2, ATF4, ERN1, IL1B, NDUFC2 | More | | Albendazole | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 3.21E-02 | 5 | P84022, Q13485, P42338, P49767, P19174 | SMAD3, SMAD4, PIK3CB, VEGFC, PLCG1 | More | | Albendazole | hsa04934 | Cushing syndrome | 4.54E-02 | 3 | P18848, Q08828, P51828 | ATF4, ADCY1, ADCY7 | More | | Albendazole | hsa04935 | Growth hormone synthesis, secretion and action | 1.88E-02 | 4 | Q08828, P51828, P18848, P31751 | ADCY1, ADCY7, ATF4, AKT2 | More | | Albendazole | hsa04961 | Endocrine and other factor-regulated calcium reabsorption | 1.22E-02 | 3 | P20020, Q9UEF7, P17252 | ATP2B1, KL, PRKCA | More | | Albendazole | hsa04970 | Salivary secretion | 1.59E-02 | 3 | Q08828, P51828, P0DP23 | ADCY1, ADCY7, CALM1 | More | | Albendazole | hsa04971 | Gastric acid secretion | 2.54E-03 | 4 | Q08828, P51828, P15311, P0DP23 | ADCY1, ADCY7, VIL2, CALM1 | More | | Albendazole | hsa04976 | Bile secretion | 1.59E-02 | 3 | Q08828, P51828, Q14032 | ADCY1, ADCY7, BAAT | More | | Albendazole | hsa05010 | Alzheimer disease | 4.94E-03 | 9 | O95298, Q00535, O75460, P0DP23, P01584, P18848, P31751, P05141, P28070 | NDUFC2, CDK5, ERN1, CALM1, IL1B, ATF4, AKT2, SLC25A5, PSMB4 | More | | Albendazole | hsa05016 | Huntington disease | 2.24E-02 | 7 | O95298, P24928, P30876, P62487, P05141, O75460, P28070 | NDUFC2, POLR2A, POLR2B, POLR2G, SLC25A5, ERN1, PSMB4 | More | | Albendazole | hsa05017 | Spinocerebellar ataxia | 3.94E-02 | 4 | O75460, P31751, P28070, P05141 | ERN1, AKT2, PSMB4, SLC25A5 | More | | Albendazole | hsa05022 | Pathways of neurodegeneration - multiple diseases | 1.67E-02 | 9 | O95298, Q8TEV9, O75460, P18848, P05141, Q00535, P01584, P0DP23, P28070 | NDUFC2, SMCR8, ERN1, ATF4, SLC25A5, CDK5, IL1B, CALM1, PSMB4 | More | | Albendazole | hsa05032 | Morphine addiction | 4.43E-02 | 3 | P63218, P50151, P43250 | GNG5, GNG10, GRK6 | More | | Albendazole | hsa05034 | Alcoholism | 2.89E-03 | 4 | Q93077, P62807, O60814, P68431 | HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | | Albendazole | hsa05132 | Salmonella infection | 1.58E-05 | 11 | P51617, P25963, P08238, Q9UJU2, Q13546, Q13489, P10415, O75369, Q13561, Q13509, P68371 | IRAK1, NFKBIA, HSP90AB1, LEF1, RIPK1, BIRC3, BCL2, FLNB, DCTN2, TUBB3, TUBB2C | More | | Albendazole | hsa05140 | Leishmaniasis | 4.05E-03 | 6 | P14598, P42224, P25963, P29350, P51617, Q15080 | NCF1, STAT1, NFKBIA, PTPN6, IRAK1, NCF4 | More | | Albendazole | hsa05143 | African trypanosomiasis | 3.19E-02 | 2 | P69905, P68871 | HBA2, HBB | More | | Albendazole | hsa05145 | Toxoplasmosis | 1.95E-02 | 6 | P51617, P25963, P10415, Q13489, P42224, P11142 | IRAK1, NFKBIA, BCL2, BIRC3, STAT1, HSPA8 | More | | Albendazole | hsa05152 | Tuberculosis | 6.22E-04 | 8 | Q13488, P0DP23, P42224, P25208, P10415, P01568, Q9UDY8, P51617 | TCIRG1, CALM1, STAT1, NFYB, BCL2, IFNA21, MALT1, IRAK1 | More | | Albendazole | hsa05162 | Measles | 4.50E-03 | 8 | P51617, P01568, P25963, P42224, P14784, P10747, P11142, P10415 | IRAK1, IFNA21, NFKBIA, STAT1, IL2RB, CD28, HSPA8, BCL2 | More | | Albendazole | hsa05163 | Human cytomegalovirus infection | 9.70E-05 | 9 | P31751, P0DP23, Q8NHW4, Q08828, P51828, P23458, P01584, Q13651, P18848 | AKT2, CALM1, CCL4L2, ADCY1, ADCY7, JAK1, IL1B, IL10RA, ATF4 | More | | Albendazole | hsa05164 | Influenza A | 4.49E-02 | 5 | P31751, P01584, P23458, P05141, Q9UBU9 | AKT2, IL1B, JAK1, SLC25A5, NXF1 | More | | Albendazole | hsa05166 | Human T-cell leukemia virus 1 infection | 2.19E-03 | 15 | P27824, P23458, P30279, P05141, P21796, P62826, Q08828, P51828, P18848, P84022, Q13485, P07766, P31751, Q92830, P06746 | CANX, JAK1, CCND2, SLC25A5, VDAC1, RAN, ADCY1, ADCY7, ATF4, SMAD3, SMAD4, CD3E, AKT2, KAT2A, POLB | More | | Albendazole | hsa05168 | Herpes simplex virus 1 infection | 5.65E-04 | 14 | P25963, P01568, P42224, Q07955, Q01130, Q13243, Q13489, P51617, Q13398, Q9NR11, P17097, P17038, Q03923, P10415 | NFKBIA, IFNA21, STAT1, SFRS1, SFRS2, SFRS5, BIRC3, IRAK1, ZNF211, ZNF302, ZNF7, ZNF43, ZNF85, BCL2 | More | | Albendazole | hsa05170 | Human immunodeficiency virus 1 infection | 3.95E-05 | 11 | P62873, P0DP23, P17252, Q13546, P01568, P51617, P25963, Q13315, P23528, P10415, Q9Y6Q5 | GNB1, CALM1, PRKCA, RIPK1, IFNA21, IRAK1, NFKBIA, ATM, CFL1, BCL2, AP1M2 | More | | Albendazole | hsa05200 | Pathways in cancer | 9.99E-07 | 33 | P04628, Q13751, P42338, P08238, P42224, P25963, P19174, Q9UJU2, P17252, P43246, P84022, Q13485, P20585, Q13547, P14923, P30279, P30281, P10415, Q13489, P49767, Q12778, P43657, P25116, P62873, P63218, P50151, Q14344, Q7LDG7, O75293, P0DP23, P01568, P14784, P01042 | WNT1, LAMB3, PIK3CB, HSP90AB1, STAT1, NFKBIA, PLCG1, LEF1, PRKCA, MSH2, SMAD3, SMAD4, MSH3, HDAC1, JUP, CCND2, CCND3, BCL2, BIRC3, VEGFC, FOXO1, P2RY5, F2R, GNB1, GNG5, GNG10, GNA13, RASGRP2, GADD45B, CALM1, IFNA21, IL2RB, KNG1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q13509 | TUBB3 | Tubulin beta-3 chain | P04628 | WNT1 | Proto-oncogene Wnt-1 | -0.709 | Q71U36 | TUBA1A | Tubulin alpha-1A chain | Q13751 | LAMB3 | Laminin subunit beta-3 | 0.748 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13751 | LAMB3 | Laminin subunit beta-3 | 0.844 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | 0.777 | Q71U36 | TUBA1A | Tubulin alpha-1A chain | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | -0.866 | P68371 | TUBB2C | Tubulin beta-4B chain | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.741 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | -0.823 | Q13509 | TUBB3 | Tubulin beta-3 chain | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.789 | Q13509 | TUBB3 | Tubulin beta-3 chain | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.733 | Q13509 | TUBB3 | Tubulin beta-3 chain | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.714 | Q71U36 | TUBA1A | Tubulin alpha-1A chain | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | -0.7 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | -0.766 | P68371 | TUBB2C | Tubulin beta-4B chain | Q9UJU2 | LEF1 | Lymphoid enhancer-binding factor 1 | -0.714 | P68371 | TUBB2C | Tubulin beta-4B chain | P17252 | PRKCA | Protein kinase C alpha type | -0.842 | Q13509 | TUBB3 | Tubulin beta-3 chain | P17252 | PRKCA | Protein kinase C alpha type | -0.756 | P68371 | TUBB2C | Tubulin beta-4B chain | P43246 | MSH2 | DNA mismatch repair protein Msh2 | 0.709 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P43246 | MSH2 | DNA mismatch repair protein Msh2 | -0.811 | Q13509 | TUBB3 | Tubulin beta-3 chain | P43246 | MSH2 | DNA mismatch repair protein Msh2 | 0.872 | Q71U36 | TUBA1A | Tubulin alpha-1A chain | P84022 | SMAD3 | Mothers against decapentaplegic homolog 3 | 0.819 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P84022 | SMAD3 | Mothers against decapentaplegic homolog 3 | 0.725 | Q71U36 | TUBA1A | Tubulin alpha-1A chain | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | -0.777 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | -0.746 | Q71U36 | TUBA1A | Tubulin alpha-1A chain | P20585 | MSH3 | DNA mismatch repair protein Msh3 | -0.745 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13547 | HDAC1 | Histone deacetylase 1 | -0.754 | P68371 | TUBB2C | Tubulin beta-4B chain | P14923 | JUP | Junction plakoglobin | -0.781 | Q13509 | TUBB3 | Tubulin beta-3 chain | P14923 | JUP | Junction plakoglobin | -0.937 | Q71U36 | TUBA1A | Tubulin alpha-1A chain | P30279 | CCND2 | G1/S-specific cyclin-D2 | -0.721 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P30281 | CCND3 | G1/S-specific cyclin-D3 | 0.743 | P68371 | TUBB2C | Tubulin beta-4B chain | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.766 | Q13509 | TUBB3 | Tubulin beta-3 chain | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.809 | P68371 | TUBB2C | Tubulin beta-4B chain | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | -0.892 | Q13509 | TUBB3 | Tubulin beta-3 chain | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | -0.716 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P49767 | VEGFC | Vascular endothelial growth factor C | 0.743 | P68371 | TUBB2C | Tubulin beta-4B chain | Q12778 | FOXO1 | Forkhead box protein O1 | -0.895 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P43657 | P2RY5 | Lysophosphatidic acid receptor 6 | -0.735 | P68371 | TUBB2C | Tubulin beta-4B chain | P25116 | F2R | Proteinase-activated receptor 1 | -0.799 | P68371 | TUBB2C | Tubulin beta-4B chain | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.82 | Q13509 | TUBB3 | Tubulin beta-3 chain | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.816 | Q71U36 | TUBA1A | Tubulin alpha-1A chain | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | 0.818 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | 0.941 | Q71U36 | TUBA1A | Tubulin alpha-1A chain | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | 0.827 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | 0.948 | Q71U36 | TUBA1A | Tubulin alpha-1A chain | Q14344 | GNA13 | Guanine nucleotide-binding protein subunit alpha-13 | 0.879 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q14344 | GNA13 | Guanine nucleotide-binding protein subunit alpha-13 | 0.87 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q7LDG7 | RASGRP2 | RAS guanyl-releasing protein 2 | 0.704 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | 0.731 | Q13509 | TUBB3 | Tubulin beta-3 chain | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | -0.826 | P68371 | TUBB2C | Tubulin beta-4B chain | P0DP23 | CALM1 | Calmodulin-1 | 0.742 | Q13509 | TUBB3 | Tubulin beta-3 chain | P0DP23 | CALM1 | Calmodulin-1 | 0.892 | P68371 | TUBB2C | Tubulin beta-4B chain | P01568 | IFNA21 | Interferon alpha-21 | -0.783 | Q13509 | TUBB3 | Tubulin beta-3 chain | P01568 | IFNA21 | Interferon alpha-21 | -0.781 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P14784 | IL2RB | Interleukin-2 receptor subunit beta | -0.835 | Q13509 | TUBB3 | Tubulin beta-3 chain | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.709 | P68371 | TUBB2C | Tubulin beta-4B chain | P01042 | KNG1 | Kininogen-1 | -0.7 |
| Albendazole | hsa05203 | Viral carcinogenesis | 2.62E-03 | 9 | P06746, Q92830, P07948, P30279, P29083, Q15283, P62807, Q93079, O60814 | POLB, KAT2A, LYN, CCND2, GTF2E1, RASA2, HIST1H2BC, H2BC9, H2BC12 | More | | Albendazole | hsa05204 | Chemical carcinogenesis | 1.48E-02 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | | Albendazole | hsa05212 | Pancreatic cancer | 2.74E-03 | 7 | P42338, P31751, Q15311, P23458, P84022, Q13485, O75293 | PIK3CB, AKT2, RALBP1, JAK1, SMAD3, SMAD4, GADD45B | More | | Albendazole | hsa05214 | Glioma | 2.90E-02 | 3 | P0DP23, Q16566, P17252 | CALM1, CAMK4, PRKCA | More | | Albendazole | hsa05215 | Prostate cancer | 6.15E-03 | 5 | P10415, Q9UJU2, Q12778, Q9NRA1, P08238 | BCL2, LEF1, FOXO1, PDGFC, HSP90AB1 | More | | Albendazole | hsa05220 | Chronic myeloid leukemia | 2.16E-02 | 5 | Q13547, Q13485, P84022, P42338, O75293 | HDAC1, SMAD4, SMAD3, PIK3CB, GADD45B | More | | Albendazole | hsa05231 | Choline metabolism in cancer | 4.70E-04 | 7 | P31751, Q9NRA1, P23743, Q16760, O14986, O14494, P17252 | AKT2, PDGFC, DGKA, DGKD, PIP5K1B, PLPP1, PRKCA | More | | Albendazole | hsa05322 | Systemic lupus erythematosus | 1.31E-04 | 5 | P09871, Q93077, P62807, O60814, P68431 | C1S, HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | | |